Top House Dem Buys Stock in Pharma Companies and Defense Contractors
The Build Back Better Act is in limbo in the U.S. House, with Democratic leaders delaying a vote on the bill on Friday, casting doubt over the fate of provisions added back into the plan that would curb prescription drug costs. In a dramatic late-night decision, Speaker Pelosi allowed a vote on the bipartisan infrastructure […]
Congress Won’t Stop Trading Stocks
Researchers studying congressional stock ownership have found that the practice has effects on lobbying activity and potentially on market movements.